| ESMCX | VESIX | ESMCX / VESIX | |
| Total Expense Ratio | 2.00 | 0.06 | 3,333% |
| Annual Report Gross Expense Ratio | 2.19 | 0.06 | 3,650% |
| Fund Existence | 26 years | 26 years | - |
| Gain YTD | 11.601 | 8.756 | 132% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 5000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 164M | 37.9B | 0% |
| Annual Yield % from dividends | 2.81 | 2.83 | 99% |
| Returns for 1 year | -17.62 | 20.48 | -86% |
| Returns for 3 years | 0.93 | 45.64 | 2% |
| Returns for 5 years | -14.00 | 33.88 | -41% |
| Returns for 10 years | 26.07 | 95.80 | 27% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| GLVIX | 90.27 | 1.58 | +1.78% |
| Invesco Global Focus R6 | |||
| BMGAX | 26.25 | 0.11 | +0.42% |
| BlackRock Mid-Cap Growth Equity Inv A | |||
| RLBCX | 40.12 | 0.08 | +0.20% |
| American Funds American Balanced R-3 | |||
| VSFAX | 29.61 | -0.10 | -0.34% |
| Federated Hermes MDT Small Cap Value A | |||
| PHLQX | 50.92 | -0.59 | -1.15% |
| PGIM Jennison Health Sciences R6 | |||